Kim Anne Campbell,Ivo Nnane,Donald Raible,Cathye Shu,Zhenhua Xu
申请号：
US16656569
公开号：
US20200121588A1
申请日:
2019.10.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided are methods of subcutaneous administration of anti-CD38 monoclonal antibodies, such as daratumumab. Also provided are methods for the treatment of autoimmune diseases with subcutaneously administered anti-CD38 monoclonal antibodies. A corticosteroid is optionally administered prior to subcutaneous administration of the anti-CD38 antibody to prevent and/or reduce systemic injection related side effects.
